Conduction abnormalities after MI
Bedside summary
Atrioventricular block and bundle-branch/fascicular block are common after acute MI, and their significance depends on the INFARCT TERRITORY and the LEVEL of block. INFERIOR MI (right coronary artery, which usually supplies the AV node) causes AV-NODAL (supra-Hisian) block: a narrow escape rhythm, often vagally mediated, usually TRANSIENT and ATROPINE-RESPONSIVE, with a good prognosis. ANTERIOR MI causes INFRANODAL (His-Purkinje) block: a wide, slow, UNRELIABLE escape, frequently needing PACING, and — because it reflects a large infarct — carries a much WORSE prognosis; a new bundle-branch or bifascicular block in anterior MI is an ominous sign. Reperfusion is the priority, and many inferior-MI blocks resolve as the artery opens.
Red flags
- Anterior MI with new bundle-branch/bifascicular block or high-grade AV block — ominous, large infarct
- Symptomatic or haemodynamically unstable bradycardia/complete block
- Wide, slow, unreliable escape rhythm (infranodal)
- Failure to respond to atropine — go to pacing
Assessment
Differential diagnosis
- Inferior-MI AV-nodal block (transient, atropine-responsive)
- Anterior-MI infranodal block / new BBB / bifascicular block (ominous)
- Drug-related block (beta-blocker, calcium-channel blocker) in the peri-MI period
- Pre-existing conduction disease
- Hyperkalaemia
Investigations
- Serial 12-lead ECGs — define the level of block (narrow vs wide escape), new BBB/fascicular block, and the infarct territory
- Continuous monitoring; electrolytes (K⁺/Mg²⁺) and drug review
- Troponin and the usual MI work-up; identify the culprit artery at angiography
- Assess haemodynamics and escape-rhythm reliability
Management
- Prioritise REPERFUSION of the underlying MI (primary PCI/fibrinolysis) — opening the artery often resolves inferior-MI block.
- Treat SYMPTOMATIC bradycardia: ATROPINE for AV-nodal (inferior-MI) block; apply transcutaneous pacing pads and correct K⁺/Mg²⁺; review/stop AV-nodal-blocking drugs.
- Use TEMPORARY (transcutaneous → transvenous) PACING for high-grade/complete block that is symptomatic or unstable — more often needed in ANTERIOR MI (unreliable infranodal escape) and for new BBB with high-grade block.
- Recognise the prognosis: inferior-MI block is usually transient with a good outlook; anterior-MI infranodal block/new BBB signals a large infarct and worse outcome — escalate and involve cardiology.
- Reassess after reperfusion — persistent high-grade block (especially anterior MI) may need a PERMANENT pacemaker; transient inferior-MI block usually does not.
Drugs & doses
Disposition
Complications & pitfalls
- Asystole/haemodynamic collapse from an unreliable escape
- Cardiogenic shock (large anterior infarct)
- Need for temporary and sometimes permanent pacing
- Death — higher with anterior-MI conduction disease
Exam pearls
- INFERIOR MI → AV-NODAL block: narrow escape, atropine-responsive, usually transient and benign (RCA supplies the AV node).
- ANTERIOR MI → INFRANODAL block: wide unreliable escape, often needs pacing, reflects a large infarct → poor prognosis.
- A NEW bundle-branch or bifascicular block in anterior MI is an ominous sign — get pacing capability ready and involve cardiology.
- Reperfuse first — many inferior-MI blocks resolve once the artery is opened.
- Atropine is for nodal (inferior) block; don’t rely on it for infranodal (anterior) block — pace.
Post-MI conduction block: read it by TERRITORY and LEVEL. Inferior MI causes a usually-transient, atropine-responsive AV-NODAL block with a good prognosis; anterior MI causes an INFRANODAL block with a wide, unreliable escape that often needs pacing and signals a large infarct (poor prognosis) — a new BBB/bifascicular block is ominous. Prioritise reperfusion, treat symptomatic bradycardia (atropine for nodal block; transcutaneous → transvenous pacing for high-grade/anterior/new-BBB block), correct electrolytes and stop AV-nodal blockers; reassess for permanent pacing after reperfusion.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.